Canna~Fangled Abstracts

Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview

By July 8, 2021July 11th, 2021No Comments
Review

. 2021 Jul 8.
doi: 10.1002/ptr.7213.

Online ahead of print.
Affiliations 

Abstract

Marijuana, or Cannabis sativa L., is a common psychoactive plant used for both recreational and medicinal purposes. In many countries, cannabis-based medicines have been legalized under certain conditions because of their immense prospects in medicinal applications. With a comprehensive insight into the prospects and challenges associated with the pharmacological use and global trade of C. sativa, this mini-review focuses on the medicinal importance of the plant and its legal status worldwide; the pharmacological compounds and its therapeutic potential along with the underlying public health concerns and future perspective are herein discussed. The existence of major compounds including Δ9 -tetrahydrocannabinol (Δ9 -THC), cannabidiol, cannabinol, and cannabichromene contributes to the medicinal effects of the cannabis plant. These compounds are also involved in the treatment of various types of cancer, epilepsy, and Parkinson’s disease displaying several mechanisms of action. Cannabis sativa is a plant with significant pharmacological potential. However, several aspects of the plant need an in-depth understanding of the drug mechanism and its interaction with other drugs. Only after addressing these health concerns, legalization of cannabis could be utilized to its full potential as a future medicine.

 

Keywords: C. sativa, anticancer, cannabinoids, ethnopharmacological properties, legalization, psychoactive drug, public health

References

REFERENCES

    1. Aaberg, K. M., Gunnes, N., Bakken, I. J., Søraas, C. L., Berntsen, A., Magnus, P., … Surén, P. (2017). Incidence and prevalence of childhood epilepsy: A nationwide cohort study. Pediatrics, 139, e20163908.
    1. Abuhasira, R., Shbiro, L., & Landschaft, Y. (2018). Medical use of cannabis and cannabinoids containing products-regulations in Europe and North America. European Journal of Internal Medicine, 49, 2-6.
    1. Adams, I. B., & Martin, B. R. (1996). Cannabis: Pharmacology and toxicology in animals and humans. Addiction, 91, 1585-1614.
    1. Adams, T. C., & Jones, L. A. (1975). Phytosterols of cannabis smoke. Journal of Agricultural and Food Chemistry, 23, 352-353.
    1. Agrawal, A., Lynskey, M. T., Bucholz, K. K., Madden, P.a. F., & Heath, A. C. (2007). Correlates of cannabis initiation in a longitudinal sample of young women: The importance of peer influences. Preventive Medicine, 45, 31-34.

Publication types


Leave a Reply